Alon Ben-Noon
Fortune : 3 M $ au 30/06/2026
Fortune : 3 M $ au 30/06/2026
Alon Ben-Noon founded Neurosense Therapeutics Ltd. in 2017, where he is working as Chief Executive Officer & Director from 2021 and Medican Consulting in 2014, where he worked as Owner from 2014 to 2017.
Mr. Ben-Noon received his undergraduate degree and Masters Business Admin degree from Ben-Gurion University of the Negev.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NEUROSENSE THERAPEUTICS LTD. 12,83 % | 16/06/2026 | 4 534 233 ( 12,83 % ) | 3 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Fondateur | 13/02/2017 |
| Sociétés | Poste | Fin |
|---|---|---|
Medican Consulting | Fondateur | 01/01/2017 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 3 |
|---|---|
Ben-Gurion University of the Negev
Ben-Gurion University of the Negev Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neurosense Therapeutics Ltd.
Neurosense Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage drug development company | Health Technology |
Medican Consulting |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national